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Apreviously well, immunocompetent 76-year-old woman with syncope and dyspnea wasreferred after a chest computed tomography examination detected a right atrioventric-ular (AoV) mass. Transesophageal echocardiography (A and B) demonstrated a large
nonspecific mass involving the right heart. Subsequent subxiphisternal biopsy confirmed a
diffuse large B-cell lymphoma. Positron emission tomography confirmed cardiac isolation.
Cardiac magnetic resonance (CMR) imaging (C and D) gradient echo (bright-blood) cine se-
quences demonstrated encroachment of the mass into the right heart (white arrows), including
a pedunculated segment within the right atrium (RA) (black arrow). There was evidence of
lymphomatous encirclement of the ascending aorta (G to I), with the right coronary artery
seen traversing through the malignancy (I, white arrow). Tagged CMR imaging sequences
demonstrated cardiac musculature integrity before chemotherapy. Follow-up CMR images
(E and F) obtained 6 months after aggressive chemotherapy (CHOP-14 plus rituximab) re-
vealed successful treatment but persistent right ventricular (RV) dilation. At 5 years, the pa-
tient remains in remission and without heart failure.
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